Xylo Technologies Ltd. (NASDAQ:XYLO) — Market Cap & Net Worth
Market Cap & Net Worth: Xylo Technologies Ltd. (XYLO)
Xylo Technologies Ltd. (NASDAQ:XYLO) has a market capitalization of $6.49 Million ($6.49 Million) as of May 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #27850 globally and #5503 in its home market, demonstrating a 0.99% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Xylo Technologies Ltd.'s stock price $5.07 by its total outstanding shares 1281040 (1.28 Million). Analyse Xylo Technologies Ltd. cash flow conversion to see how efficiently the company converts income to cash.
Xylo Technologies Ltd. Market Cap History: 2015 to 2025
Xylo Technologies Ltd.'s market capitalization history from 2015 to 2025. Data shows change from $4.79 Billion to $6.49 Million (-50.82% CAGR).
Index Memberships
Xylo Technologies Ltd. is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.41 Trillion | 0.00% | #819 of 976 |
Weight: Xylo Technologies Ltd.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Xylo Technologies Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Xylo Technologies Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.16x
Xylo Technologies Ltd.'s market cap is 0.16 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.01 Billion | $548.87K | -$9.00 Million | 1838.16x | N/A |
| 2017 | $235.71 Million | $467.00K | -$2.54 Million | 504.73x | N/A |
| 2018 | $116.07 Million | $436.00K | -$6.60 Million | 266.22x | N/A |
| 2019 | $77.68 Million | $273.00K | -$14.18 Million | 284.53x | N/A |
| 2020 | $85.27 Million | $531.00K | -$4.33 Million | 160.58x | N/A |
| 2021 | $44.64 Million | $10.12 Million | $6.79 Million | 4.41x | 6.57x |
| 2022 | $15.95 Million | $91.86 Million | -$9.81 Million | 0.17x | N/A |
| 2023 | $11.14 Million | $91.72 Million | -$16.02 Million | 0.12x | N/A |
| 2024 | $4.64 Million | $29.86 Million | -$6.03 Million | 0.16x | N/A |
Competitor Companies of XYLO by Market Capitalization
Companies near Xylo Technologies Ltd. in the global market cap rankings as of May 4, 2026.
Key companies related to Xylo Technologies Ltd. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #141 globally with a market cap of $155.56 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #208 globally with a market cap of $112.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #236 globally with a market cap of $102.56 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #141 | Abbott Laboratories | NYSE:ABT | $155.56 Billion | $89.46 |
| #208 | Stryker Corporation | NYSE:SYK | $112.79 Billion | $294.73 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | NYSE:MDT | $102.56 Billion | $80.00 |
Xylo Technologies Ltd. Historical Marketcap From 2015 to 2025
Between 2015 and today, Xylo Technologies Ltd.'s market cap moved from $4.79 Billion to $ 6.49 Million, with a yearly change of -50.82%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $6.49 Million | +40.06% |
| 2024 | $4.64 Million | -58.36% |
| 2023 | $11.14 Million | -30.19% |
| 2022 | $15.95 Million | -64.26% |
| 2021 | $44.64 Million | -47.64% |
| 2020 | $85.27 Million | +9.77% |
| 2019 | $77.68 Million | -33.08% |
| 2018 | $116.07 Million | -50.76% |
| 2017 | $235.71 Million | -76.64% |
| 2016 | $1.01 Billion | -78.92% |
| 2015 | $4.79 Billion | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of Xylo Technologies Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.49 Million USD |
| MoneyControl | $6.49 Million USD |
| MarketWatch | $6.49 Million USD |
| marketcap.company | $6.49 Million USD |
| Reuters | $6.49 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Xylo Technologies Ltd.
Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Great Britain, Israel, Canada, Asia, and internationally. It operates through Corporate, Online Advertising & Internet Traffic Routing, Online Event Management, and Real-estate and Electronics segments. The company offers Medigus Ultrasonic Surgical Endostapler, an endosc… Read more